CatalentNYSE: CTLT

Shares of Catalent Inc CTLT, which manufactures Elevidys, are trading higher with a strong session volume of 3.6 million compared to an average volume of 1.6 million.

Catalent (CTLT) reported earnings 30 days ago. What's next for the stock?

Catalent said on Wednesday its stockholders have voted to approve its deal with Novo Holdings, the parent company of Novo Nordisk.

Catalent's partnership will aid in producing safe, high-quality AAV gene therapies for cancer patients, potentially saving lives.

Investors interested in Medical - Drugs stocks may have come across both Takeda Pharmaceutical Co. (TAK) and Catalent (CTLT). However, which of these stocks offers a more attractive value opportunity at the moment?

The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S. Federal Trade Commission (FTC) for approval of a $16.5 billion deal to buy manufacturing subcontractor Catalent , a spokesperson said on Monday.

International Companies Drive Diabesity Innovation

Novo Holdings CEO Kasim Kutay discusses the surge in income from obesity drug sales and offers an update on the Catalent deal and insight on the company's deal strategy.

Novo Nordisk expects to close its acquisition of Catalent later this year, its chief financial officer said during the company's capital markets day on Thursday, adding that Novo's gross margin is seen falling in the coming years.